Libero da leggere

18F-fluorodeoxyglucose and 18F-flumazenil positron emission tomography in patients with refractory epilepsy

Marina Hodolic

Marina Hodolic

Cerca questo autore su
Sciendo|Google Scholar
Hodolic, Marina
, 
Raffi Topakian

Raffi Topakian

Cerca questo autore su
Sciendo|Google Scholar
Topakian, Raffi
 e 
Robert Pichler

Robert Pichler

Cerca questo autore su
Sciendo|Google Scholar
Pichler, Robert
  
19 lug 2016
18F-fluorodeoxyglucose and 18F-flumazenil positron emission tomography in patients with refractory epilepsy's Cover Image
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Cita
Scarica la copertina
Categoria dell'articolo: Review Article
Pubblicato online: 19 lug 2016
Pagine: 247 - 253
Ricevuto: 23 feb 2016
Accettato: 29 apr 2016
DOI: https://doi.org/10.1515/raon-2016-0032
Parole chiave
© 2016 Radiol Oncol
This content is free.

Figure 1

Focal epilepsy in 17 year old male patient. Interictal 18F-FDG PET (A): physiological distribution of 18F-FDG in the brain. Ictal 18F-FDG PET (B): hypermetabolism frontolateral in the right hemisphere (arrow).
Focal epilepsy in 17 year old male patient. Interictal 18F-FDG PET (A): physiological distribution of 18F-FDG in the brain. Ictal 18F-FDG PET (B): hypermetabolism frontolateral in the right hemisphere (arrow).

Figure 2

18F-FDG PET (B)scan vs. 18F-Flumazenil PET (C)in a 19 year old female patient with bilateral hippocampal sclerosis as shown by MRI (A). Both PET modalities present low temporomesial uptake being larger on the left side, but benzodiazepinereceptor imaging appears sharper and presents a focal defect.
18F-FDG PET (B)scan vs. 18F-Flumazenil PET (C)in a 19 year old female patient with bilateral hippocampal sclerosis as shown by MRI (A). Both PET modalities present low temporomesial uptake being larger on the left side, but benzodiazepinereceptor imaging appears sharper and presents a focal defect.

Figure 3

Focal epilepsy in 56 year old male patient. (A)MRI: astrogliosis of the right hippocampus (later proven by histology); (B)18F-FDG PET: minal temporomesial hypometabolism of both sides; (C)18F-Flumazenil PET: focal defect of tracer uptake at the right hippocampus.
Focal epilepsy in 56 year old male patient. (A)MRI: astrogliosis of the right hippocampus (later proven by histology); (B)18F-FDG PET: minal temporomesial hypometabolism of both sides; (C)18F-Flumazenil PET: focal defect of tracer uptake at the right hippocampus.

Some PET tracers used for imaging of epileptic focus and PET scan findings

PET scanFindings on PET scan
18F-FDG interictalDecreased metabolism
18F-FDG ictalIncreased and decreased metabolism (complex pattern)
18F-FDG postictalIncreased and decreased metabolism (complex pattern)
Serotonin receptor (e.g. 18F-Mefway)Reduced binding
Dopamine receptor (e.g. 18F-Fallypride)Reduced binding
18F-Flumazenil (GABA receptor)Decreased binding
15O-H2O interictalReduced perfusion
15O-H2O ictalIncreased perfusion
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicina, Medicina clinica, Medicina interna, Ematologia, Oncologia, Radiologia
Feed RSS della rivista